Delphi Pharma works alongside its
clients to address the critical strategic issues found in the global
pharmaceutical and biotechnology industries
M&A/licensing
What are the organization's partnering needs?
Who are the most appropriate and valuable partners?
What is the most appropriate deal type and structure?
What is the deal's financial and strategic value?
Portfolio management/competitive positioning
Do current therapeutic franchises guarantee shareholder
returns over the next 5 years?
Where does the organization want to be in 5 years time and
how does it get there?
What are the portfolio gaps and how can they be filled?
How can the organization compete more effectively with its
leading competitors?
Competitor benchmarking
How do competitors structure their organization and what can
be learned and improved upon?
How do competitors structure their sales force and how can
the organization compete more effectively?
How do competitors market their products and how should the
organization position its products?
How do competitors structure their licensing deals and what
are industry best practices in deal-making?
Executive issues
How can physicians be effectively targeted through
eDetailing?
How can the organization leverage returns from DTC marketing
and disease management programs?
Does orphan drug designation have a positive impact on total
product returns?
How can the negative effects of parallel importing be
minimized?
Independent Strategic Decision
Analysis 
